pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

13,368 catalysts · 3,392 8k filing · 2,401 grant · 2,076 approval · 1,436 device 510k · 1,072 device recall · 1,000 device adverse event

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 12 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-29×clear all
type
  • 8k filing3,392
  • grant2,401
  • approval2,076
  • device 510k1,436
  • device recall1,072
  • device adverse event1,000
device pma
950
  • earnings584
  • recall376
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Nov 3, 2025

    50
    ›Nov 5, 2025device pma287d agoPromega Corporation — OncoMate® MSI Dx Analysis System (PMA)

    Product code: SFL. Advisory committee: MG. Decision: APPR

    full page →fda device pma ↗
    ›Nov 5, 2025device recall287d agoCepheid device recall (Cls II)

    Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10. — Reason: Product testing did not meet expected stability criteria. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 5, 2025device recall287d agoDiasol, Inc device recall (Cls II)

    Brand Name: Diasol Product Name: 100425-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non Pyrogenic, 2K, 3.0CA, 1.0MG, 208.2 liters — Reason: Safety and efficacy of dialysis acid concentrate cannot be assured — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 5, 2025device recall287d agoDiasol, Inc device recall (Cls II)

    Brand Name: Diasol Product Name: 100225-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non Pyrogenic, 2K, 3.0CA, 1.0MG, 208.2 liters — Reason: Safety and efficacy of dialysis acid concentrate cannot be assured — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 5, 2025device recall287d agoDiasol, Inc device recall (Cls II)

    Brand Name: Diasol Product Name: 100220-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non Pyrogenic, 2K, 3.0CA, 1.0MG, 208.2 liters — Reason: Safety and efficacy of dialysis acid concentrate cannot be assured — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 5, 2025device recall287d agoDiasol, Inc device recall (Cls II)

    Brand Name: Diasol Product Name: 100325-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non Pyrogenic, 2K, 3.0CA, 1.0MG, 208.2 liters — Reason: Safety and efficacy of dialysis acid concentrate cannot be assured — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 5, 2025device recall287d agoAccriva Diagnostics, Inc. device recall (Cls II)Co-Diagnostics, Inc.

    Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System — Reason: Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 5, 2025device recall287d agoDiasol, Inc device recall (Cls II)

    Brand Name: Diasol Product Name: 100125-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non Pyrogenic, 2K, 3.0CA, 1.0MG, 208.2 liters — Reason: Safety and efficacy of dialysis acid concentrate cannot be assured — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 5, 2025device recall287d agoDiasol, Inc device recall (Cls II)

    Brand Name: Diasol Product Name: 100230-10-DEX100, Liquid Concentrate for Bicarbonate Dialysis Non Pyrogenic, 2K, 3.0CA, 1.0MG, 208.2 liters — Reason: Safety and efficacy of dialysis acid concentrate cannot be assured — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 6, 2025approval286d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗
    ›Nov 6, 2025approval286d agoVOQUEZNA (VONOPRAZAN FUMARATE) — FDA approvalvonoprazan fumarate

    Sponsor: PHATHOM. Form: TABLET. Route: ORAL

    full page →vonoprazan fumarate →fda approvals ↗
    ›Nov 6, 2025approval286d agoSUMATRIPTAN SUCCINATE — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: ALEMBIC. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    ›Nov 6, 2025approval286d agoSIMLANDI (ADALIMUMAB-RYVK) — FDA approvalAlvotech

    Sponsor: ALVOTECH USA INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalIpca Pharmaceuticals Inc

    Sponsor: PH HEALTH. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalIpca Pharmaceuticals Inc

    Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoPIPERACILLIN (PIPERACILLIN SODIUM) — FDA approvalIstituto Biochimico Italiano Giovanni Lorenzini Spa

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoCETRORELIX ACETATE — FDA approvalEMD Serono Inc

    Sponsor: TEVA PHARMS INC. Form: POWDER. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoCETRORELIX ACETATE — FDA approvalEMD Serono Inc

    Sponsor: TEVA PHARMS INC. Form: POWDER. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: SANDOZ. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Nov 6, 2025approval286d agoPIPERACILLIN (PIPERACILLIN SODIUM) — FDA approvalIstituto Biochimico Italiano Giovanni Lorenzini Spa

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: STERISCIENCE. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoDASATINIB — FDA approvalDASATINIB

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →DASATINIB →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoNELARABINE — FDA approvalNELARABINE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INTRAVENOUS

    full page →NELARABINE →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 6, 2025approval286d agoBUPROPION HYDROCHLORIDE — FDA approvalIpca Pharmaceuticals Inc

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Nov 6, 2025device 510k286d agoVenus Concept, Inc. — Venus Nova (FP-2001) (510k cleared)

    Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoMotive Health, Inc. — Motive™ Muscle Stimulator for Lower Back (OT01-1003) (510k cleared)

    Product code: NGX. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoAdaptix Limited — Adaptix Ortho350 (510k cleared)

    Product code: IZF. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoHefei Chimed Intelligent Machine Co., Ltd. — Dual-Mode Mobile C-Arm (Geelin500A, Geelin500M) (510k cleared)

    Product code: OXO. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoPace Surgical — Ultra™ Compression Screw System (510k cleared)

    Product code: HWC. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoAiomega, LLC — AIO Breathe (510k cleared)

    Product code: LRK. Advisory committee: Dental. Type: Abbreviated

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoAidoc Medical , Ltd. — BriefCase-Triage (510k cleared)

    Product code: QAS. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoTandem Diabetes Care, Inc. — Tandem Mobi insulin pump with interoperable technology (510k cleared)TANDEM DIABETES CARE INC

    Product code: QFG. Advisory committee: Clinical Chemistry. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoMedical Bees GmbH — mb-FIX Cranial Stabilization Systems (510k cleared)

    Product code: HBL. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoStereotaxis, Inc. — Stereotaxis GenesisX RMN with Navigant ™ Workstation (NWS) (510k cleared)Stereotaxis, Inc.

    Product code: DXX. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoCatalyst Orthoscience, Inc. — Catalyst F1x Shoulder System (510k cleared)

    Product code: KWS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoHebei Keylaser Sci-Tech Co.,Ltd — Q-Switched Nd:Yag laser (K690) (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoHubly, Inc. — Hubly Drill (H100) (510k cleared)Petros Pharmaceuticals, Inc.

    Product code: HBE. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device 510k286d agoDmp Dental Industry S.A. — MAGNABOND SE; MAGNABOND UNIVERSAL; MAGNABOND UNIVERSAL DCA (510k cleared)

    Product code: KLE. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 6, 2025device pma286d agoNyxoah S.A. — Genio® System 2.1 (PMA supplement)Nyxoah SA

    Supplement type: Normal 180 Day Track No User Fee. Product code: MNQ. Advisory committee: AN. Decision: APPR

    full page →fda device pma ↗
    ›Nov 6, 2025device pma286d agoStryker Leibinger GmbH & Co KG — Adherus AutoSpray Dural Sealant (PMA supplement)

    Supplement type: 135 Review Track For 30-Day Notice. Product code: NQR. Advisory committee: NE. Decision: APPR

    full page →fda device pma ↗
    ›Nov 6, 2025device pma286d agoPhysio-Control, Inc. — LIFEPAK® CR2 Automated External Defibrillator (PMA supplement)

    Supplement type: Real-Time Process. Product code: MKJ. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Nov 6, 2025device pma286d agoBoston Scientific Corp — WATCHMAN FLX Pro Left Atrial Appendage Closure Device with Delivery System; WATCHMAN FLX Left Atrial Appendage Closure D (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Special (Immediate Track). Product code: NGV. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Nov 6, 2025device recall286d agoC.R. Bard Inc device recall (Cls II)

    BD InLay Optima Ureteral Stent Kit Size: 6 Fr. x 30 cm, Ureteral Stent Kit REF 788630 — Reason: Labeling discrepancy; Ureteral stent actual size may not match the actual product label. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 6, 2025device recall286d agoPATH device recall (Cls II)PATH

    MADSEN ACCUSCREEN TEOAE/DPOAE/ABR Probe (P/N 8-69-41100) — Reason: Following a component change in the DPOAE probe (speaker replacement), technical distortions may occur at high stimulus levels combined with unusually low OAE amplitude acceptance thresholds. These distortions can mimic true DPOAE responses and may result in a false PASS outcome. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 6, 2025device recall286d agoC.R. Bard Inc device recall (Cls II)

    Bard InLay Optima Size: 6 Fr. x 14 cm, Ureteral Stent Kit REF 787614 — Reason: Labeling discrepancy; Ureteral stent actual size may not match the actual product label. — Status: Ongoing

    full page →fda device recalls ↗
    ← prev
    page 12 of 268
    next →
    $CODX1.51000.00%
    $PHAT9.3600+0.86%
    $ALVO3.9450+1.68%
    $PYPD4.6650-2.20%
    $BSX51.23-0.40%
    $STXS1.8800+5.62%
    $PTPI
    $NYXH
    $TNDM23.04+3.53%
    $AMRX18.72+1.63%